Katarina Sjögreen Gleisner

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative ¹⁷⁷Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy

Michael Ljungberg, A. Ćeller, Mark Konijnenberg et al. · Journal of Nuclear Medicine · 2015 · 350 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands

Katarina Sjögreen Gleisner, Nicolas Chouin, Pablo Mínguez Gabiña et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 234 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations

Jonathan Gear, M G Cox, Johan Gustafsson et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 228 citations · Full text

Medicine, Oncology, Radiation Oncology +17

¹⁷⁷Lu‐[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy

Michael Garkavij, Mattias Nickel, Katarina Sjögreen Gleisner et al. · Cancer · 2010 · 212 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Anna Sundlöv, Katarina Sjögreen Gleisner, Johanna Svensson et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 206 citations · Full text

Medicine, Nuclear Medicine, Oncology +17